Telemetry Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Telemetry Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-60,000	Closed	-$4.76M	–	181
2022 Q3	$4.76M	Buy	+60,000	New	+$5.06M	6.1%	2
2019 Q3	–	Sell	-200,000	Closed	-$17.5M	–	67
2019 Q2	$17.5M	Sell	200,000 -245,000	-55%	-$20.9M	13.55%	1
2019 Q1	$40.3M	Buy	445,000 +295,000	+197%	+$25.1M	20.46%	1
2018 Q4	$10.8M	Sell	150,000 -117,000	-44%	-$9.43M	6.86%	2
2018 Q3	$25.6M	Buy	267,000 +17,000	+7%	+$1.65M	11.61%	2
2018 Q2	$23.8M	Sell	250,000 -20,000	-7%	-$1.84M	9.06%	2
2018 Q1	$23.7M	Buy	270,000 +20,000	+8%	+$1.83M	8.87%	3
2017 Q4	$21.2M	Sell	250,000 -50,000	-17%	-$4.19M	8.09%	3
2017 Q3	$26M	Buy	300,000 +50,000	+20%	+$4.01M	9.28%	3
2017 Q2	$19.3M	Buy	250,000 +132,000	+112%	+$9.36M	9.08%	3
2017 Q1	$8.18M	Buy	118,000 +28,000	+31%	+$1.88M	3.67%	4
2016 Q4	$5.33M	Buy	90,000 +80,000	+800%	+$4.94M	3.01%	5
2016 Q3	$663K	Sell	10,000 -170,000	-94%	-$10.5M	0.42%	43
2016 Q2	$9.74M	Sell	180,000 -60,000	-25%	-$3.29M	5.24%	3
2016 Q1	$12.4M	Buy	+240,000	New	+$12.5M	3.61%	3

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Telemetry Investments's XBI Position: Q3 2022 in Review

Telemetry Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 10,500 shares — an estimated $885K sold.

Telemetry Investments first reported a position in XBI in Q2 2017 and held it in 4 quarters. The position peaked at $1.12M in Q4 2021. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Telemetry Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
Telemetry Investments sold 10,500 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $885K.
Telemetry Investments first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and held it in 4 quarters.
Telemetry Investments's State Street SPDR S&P Biotech ETF position peaked at $1.12M in Q4 2021.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Telemetry Investments's 13F filing for Q3 2022, filed 17 Nov 2022.